Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GPR55 antisense RNA 1 (GPR55-AS1) is a long non-coding RNA (lncRNA) gene affiliated with the lncRNA class. It is transcribed in the human genome in the antisense orientation to the GPR55 gene (a G protein-coupled receptor). The biological function, disease associations, interacting drugs, and safety concerns of GPR55-AS1 have not been clearly established in available public resources. It is not considered a therapeutic target or receptor, but may play a regulatory role in gene expression as is typical of long non-coding RNAs.
None (no mechanism of drug action, as it is not a classic pharmacological target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GPR55 antisense RNA 1 (GPR55-AS1).